Morgan Stanley analyst Erin Wright raised CVS Health’s price target to $89 and maintains an Overweight rating on the stock. Last week’s results were “encouraging”, and Managed Care Organization sentiment has “improved slightly”. Investors should focus on utilization and early reads on 2026.

TipRanks Premium is currently offering a 50% discount on powerful investing tools, advanced data, and expert analyst insights. Take advantage of this offer to invest with confidence and make informed decisions.

Stay informed with real-time, market-moving breaking financial news from TheFly, the ultimate source for up-to-date information. Try out their services now for the latest updates and analysis on the market.

For more insights on CVS Health and other top insider trading stocks, visit TipRanks to see the latest information and trends in the market. Stay informed and make well-informed investment decisions with the help of their data and analysis tools.

Read more at Yahoo Finance: CVS Health price target raised to $89 from $82 at Morgan Stanley